Eclipse Diagnostics

Early Stage

Preventing Stroke At Home


Raised to Date: Raised: $171,750

Total Commitments ($USD)



Start Date


Close Date


Min. Goal


Max. Goal


Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share


Pre-Money Valuation


Rolling Commitments ($USD)

Reporting Date


Days Remaining
% of Min. Goal


% of Max. Goal


Likelihood of Max
Avg. Daily Raise


# of Investors


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Farming & Agriculture

Tech Sector



Los Angeles, California

Who Should Be Interested:
Are you a stroke survivor, or a diabetic patient? Do you know someone who has experienced the scariness of a stroke? If you are, or if you have, then investing in Eclipse Diagnostics could be the move for you. They’re developing an innovative new technology that will help prevent strokes at home.

The Company:
Eclipse Diagnostics wants to truly help eclipse the surprise of strokes. They’re developing an easy-to-use home device to monitor the risk of stroke -- and hopefully prevent it. There is a blood marker that, when elevated, indicates a high risk of stroke. By monitoring this blood marker at least once a week, patients will be able to see early warning signs and visit a doctor for further diagnostics. Eclipse’s patented technology and device is easy to use. Users simply prick their finger for a drop of blood, put it into the disposable one-time-use test strip, and a bluetooth device reads the strip. The device connects to a smartphone app that gathers and processes the information, and if the user’s biomarkers reach dangerous levels, the app will provide a warning and alert. This is the first device of its kind to allow patients to monitor their stroke risk at home -- and take preventable action as a result.

The Bottom Line:
Stroke is currently the fifth leading cause of death in the US -- but up to 80% of strokes can be prevented. Eclipse Diagnostics is giving diabetics and at-risk patients the chance to monitor early warning signs, reach out to a doctor when needed...and ultimately prevent the stroke from happening at all.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Eclipse Diagnostics 04/29/2020 StartEngine $11,189,805 $179,058 Equity - Common Funded RegCF
Eclipse Diagnostics 10/31/2018 StartEngine $10,000,000 $171,750 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.
Are you the founder of Eclipse Diagnostics? Create your account today to claim this raise page.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Eclipse Diagnostics on StartEngine
Platform: StartEngine
Security Type: Equity - Common
Valuation: $10,000,000

Follow company

Follow Eclipse Diagnostics on StartEngine
View on StartEngine (Closed)